Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs.

Berte N, Piée-Staffa A, Piecha N, Wang M, Borgmann K, Kaina B, Nikolova T.

Mol Cancer Ther. 2016 Nov;15(11):2665-2678. Epub 2016 Jul 29.

2.

Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.

Usanova S, Piée-Staffa A, Sied U, Thomale J, Schneider A, Kaina B, Köberle B.

Mol Cancer. 2010 Sep 16;9:248. doi: 10.1186/1476-4598-9-248.

3.

Synthesis of 131I-labeled glucose-conjugated inhibitors of O6-methylguanine-DNA methyltransferase (MGMT) and comparison with nonconjugated inhibitors as potential tools for in vivo MGMT imaging.

Mühlhausen U, Schirrmacher R, Piel M, Lecher B, Briegert M, Piee-Staffa A, Kaina B, Rösch F.

J Med Chem. 2006 Jan 12;49(1):263-72.

PMID:
16392811
4.

Inhibition of O6-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors: comparison with nonconjugated inhibitors and effect on fotemustine and temozolomide-induced cell death.

Kaina B, Mühlhausen U, Piee-Staffa A, Christmann M, Garcia Boy R, Rösch F, Schirrmacher R.

J Pharmacol Exp Ther. 2004 Nov;311(2):585-93. Epub 2004 Jul 13.

PMID:
15254145
5.

Activation of promutagens by endogenous and heterologous sulfotransferases expressed in continuous cell cultures.

Glatt H, Pauly K, Piée-Staffa A, Seidel A, Hornhardt S, Czich A.

Toxicol Lett. 1994 Jun;72(1-3):13-21.

PMID:
8202924

Supplemental Content

Loading ...
Support Center